Search Results
Results found for "Bridge Biotherapeutics"
- Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify...
We found that a proposed disulfide bridge between the N-terminus and extracellular loop 3, present in
- Conjugation Strategies for Probe Development
Its biggest advantage is the presence of Cys residues in proteins, although sometimes S-S bridge reduction
- Integrated GPCR Drug Discovery: A Structured Framework for Modern Programs
biology capabilities with the scientists and organizations positioned to use them — strengthening the bridge
- How System-Level GPCR Thinking Prevents Discovery Failures
His work shows why chemical design can outperform antibodies and how rigorous assay validation bridges
- How GPCR Collaboration Built an Innovation Engine
Senior postdocs acted as bridges, not gatekeepers.
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
It took data, yes—but also a deep partnership with GPCR legend Terry Kenakin to bridge industry credibility
- GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors
These sessions bridge structural biology , computational modeling , and clinical translation — with
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
This approach makes her models not just rigorous, but translational—bridging the gap between receptor
- Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
Over the next five bi-weekly installments, " The GPCR Precision Blueprint " series will unpack how to bridge
- How Collaboration Drives GPCR Discoveries
How GPCR Collaboration Bridges Chemistry and Physiology Great collaborations often begin where frustrations
- From Snapshots to Predictions: Why Mechanism of Action Matters
Models are the bridge.
- Drug Discovery Pharmacology Principles That Turn Assays Into Real Medicines
Pharmacology exists precisely to bridge that gap.
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
This would help bridge the gap between in-vitro findings and clinical outcomes.
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
Bridge science and strategy: Ensure data and decision-making align with funding and milestones.
- Dr. GPCR Updates
This partnership aims to bring advanced chemical probe strategies to the forefront.
- From Multiplex to Models: Scaling Up GPCR Discovery in the Post-Silo Era
validation Training the Next Wave Graduate students and visiting scientists are already expanding this work, bringing
- RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. Lübeck, Germany...
Therefore, the aim of this symposium is to bring together the current knowledge on the role of autoantibodies In addition, one aim is to bring together the mode of action of autoantibodies in immune regulation and
- Let’s work better together!
📌Our mission is to bring together all key players under one umbrella to co-exist in the @DrGPCR Ecosystem
- Sign Up Now!
🌐 🤝 We want to bring closer the #GPCR community! Join the Dr.
- Inverse Agonists, Lymphatic Fixes & β-arrestin Tricks
This week brings sharp new insights into how minor changes in ligand structure can flip GPCR function
- From Student to Mentor: What Alessandro Nicoli Learned About Leading in Science
Students bring fresh perspectives, and in teaching them, he also sharpens his own skills.
- Are You Guessing or Forecasting? Master GPCR Pharmacologic Models Before It’s Too Late
Access your exclusive discount in the full newsletter Secure Your Access Now ➤ 🗣️ “Thank you for bringing
- Sosei Heptares recently hosted their annual Scientific Advisory Board (SAB)
It was great to bring everyone together and also welcome new member John Parkinson."
- When Pain Becomes a Catalyst: How Personal Experience Redefined One Scientist’s Mission
What makes Serafini’s trajectory so compelling isn’t just his technical training — it’s the urgency he brings
- Carola Weiss joins InterAx Biotech AG as VP Business Development
Carola Weiss’ professional career brings deep expertise in business development, marketing & sales, licensing
- Building Backwards: Why Top-Down Models Could Revolutionize Pain Research
"I'm particularly interested in model development... seeing if we can bring preclinical models much closer
- 4GPCRnet, September 26-29, 2022. Leipzig, Germany
August 2022 "WELCOME 4GPCRnet meeting bringing together four of the biggest GPCR networks in Europe for
- Anatomy of a partnership: Cancer Research UK teams up with Sosei Heptares
2022 Cancer Research UK is working with global biopharma Sosei Heptares on a treatment they hope will bring
- Cancer Research UK and Sosei Heptares sign agreement to advance cancer immunotherapy candidate ...
the world’s largest private funder of cancer research, today announce the signing of an agreement to bring
- Terry’s Corner, Celtarys' Leap, and the $7B GPCR Horizon
Terry Kenakin brings translational clarity to complex receptor concepts.
